REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/12/2025
Voltar para busca
Dado oficial do USPTO
EVICORE ONCONNECT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EVICORE ONCONNECT
ST13
US500000088255839Classe
35, 36, 42, 44
Pedido
88255839
Registro
6211778
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
02/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 42, 44
Data de depósito
09/01/2019
Data de registro
01/12/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/12/2020
Última transação
02/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2020-04-00
Primeiro uso no comércio
2020-04-00
Código do desenho
4
Tipo de titular
16
Localização do titular
BLUFFTON, SC
Examinador
RANNS, NATHAN
Unidade examinadora
O10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EVICORE HEALTHCARE MSI, LLC
CareCore National, LLC
Representantes
Alexandra MacKay STITES & HARBISON, PLLC
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Cost management for the health care benefit plans of others; Drug utilization review services; pharmaceutical cost management services; medical cost management; managed care servicesutilization review and pre-certification services; evidence-based health care cost management services and healthcare utilization and review services; Patient care management servicespharmaceutical cost management; medical and pharmaceutical cost management services in the fields of medical oncologyradiation therapygenetic laboratory servicesdiagnostic radiologyinpatient admissionscancer surgeryhealthcare services in the field of oncology
Classe 36
Pharmacy benefit management services; medical benefit management services; medical and pharmacy benefit management servicestrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug usemedical carehealthcare habitsto identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchaserspayersprovidersbeneficiaries of health plans; administration of managed health care plans
Classe 42
Software as a service (SaaS) services featuring software for use with evidence-based healthcare and insurancemedical utilization review and reporting and verifying the requesting provider's adherence to evidence-based medical and pharmacy guidelines; software as a service (SaaS) services featuring software for optimizing healthcare utilizationmanaging utilization and financial risk for healthcare payersassisting physicians in making clinical decisionsanalyzing data to help health care providers track clinical decisions and develop best practices; providing online non-downloadable software for use in managing the quality and cost of healthcare; providing online non-downloadable software for use in obtaining prior authorizations for care to aid in schedule services and delivering care to patients; software as a service (SaaS) services featuring software for the use with managing medical and pharmacy benefits in the fields of medical oncologyradiation therapygenetic laboratory servicesdiagnostic radiologyinpatient admissionscancer surgeryhealthcare services in the field of oncology; organization and coordination of health care servicesgenetic laboratory services
Classe 44
advisory services and consultancy regarding healthcare; healthcare servicesdisease management programs; organization and coordination of health care servicesmedical oncology servicesradiation therapydiagnostic radiology serviceshospital admissionssurgery
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
19/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/10/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
24/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/10/2020
EX2G
SOU EXTENSION 2 GRANTED
02/10/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/10/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/10/2020
IUAF
USE AMENDMENT FILED
25/09/2020
EXT2
SOU EXTENSION 2 FILED
25/09/2020
EEXT
SOU TEAS EXTENSION RECEIVED
25/09/2020
EISU
TEAS STATEMENT OF USE RECEIVED
25/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/03/2020
EX1G
SOU EXTENSION 1 GRANTED
26/03/2020
EXT1
SOU EXTENSION 1 FILED
26/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
26/03/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2019
PUBO
PUBLISHED FOR OPPOSITION
06/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/07/2019
ALIE
ASSIGNED TO LIE
01/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/06/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
20/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
20/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/04/2019
GNRT
NON-FINAL ACTION E-MAILED
01/04/2019
CNRT
NON-FINAL ACTION WRITTEN
01/04/2019
DOCK
ASSIGNED TO EXAMINER
25/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/01/2019
NWAP
NEW APPLICATION ENTERED
12/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EVICORE ONCONNECT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.